02.03.2015 • NewsDede WillamsBASFToda Kogyo

BASF and Toda Kogyo Agree JV on Cathode Materials for Batteries

Germany's BASF and Toda Kogyo of Japan have finalized their joint venture agreement on production of cathode active materials (CAM) for lithium-ion batteries in Japan. The deal was first announced in October 2014.

The Japanese joint venture will operate as part of BASF's global Battery Materials business. It will be able to leverage BASF's position as the leading chemical supplier to the automotive industry as well as Toda Kyogo's marketing and technical capabilities and its extensive know-how in the battery materials sector.

BASF Japan will hold 66%, its Japanese partner 34% of the equity in the jv, BASF TODA Battery Materials, which will conduct research and development, production, marketing and sales for a broad range of cathode materials, particularly NCA (Nickel Cobalt Aluminum Oxide), LMO (Lithium Manganese Oxide) and NCM (Nickel Cobalt Manganese) in Japan.

The materials are used in lithium-ion batteries for the automotive, consumer electronics and stationary storage markets.

Headquarters of the new company will be in Minato-ku, Tokyo, and it will have production facilities in Sanyo-Onoda city, Yamaguchi Prefecture, and Kita-Kyushu city, Fukuoka Prefecture, Japan.

Around 80 people will work for the joint venture, which will have annual combined production capacity for cathode active materials and their precursors of approximately 18,000 t/y.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.